首页> 美国卫生研究院文献>Mediators of Inflammation >IgE-mediated histamine release from nasal mucosa is inhibited by SLPI (secretory leukocyte protease inhibitor) to the level of spontaneous release.
【2h】

IgE-mediated histamine release from nasal mucosa is inhibited by SLPI (secretory leukocyte protease inhibitor) to the level of spontaneous release.

机译:IgE介导的组胺从鼻粘膜释放被SLPI(分泌型白细胞蛋白酶抑制剂)抑制到自发释放水平。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The secretory leukocyte protease inhibitor (SLPI) is a low-molecular-weight inhibitor of proteases, such as elastase and cathepsin G which are released from leukocytes during phagocytosis. The purpose of this study was to determine whether or not SLPI is able to inhibit IgE-mediated histamine release. Nasal mucosa from 11 test subjects without atopic disposition was used for this in vitro study. We found that SLPI inhibited histamine release in a dose-dependent way but was without influence on the spontaneous release.
机译:分泌型白细胞蛋白酶抑制剂(SLPI)是蛋白酶的低分子量抑制剂,例如在吞噬过程中从白细胞释放的蛋白酶,例如弹性蛋白酶和组织蛋白酶G。这项研究的目的是确定SLPI是否能够抑制IgE介导的组胺释放。来自11名无特应性的测试对象的鼻黏膜用于该体外研究。我们发现SLPI以剂量依赖的方式抑制组胺的释放,但对自发释放没有影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号